Overview
- 7 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2024-03-15.
At a glance
Inspections
7
Form 483s
7
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 6 Feb 2024 – 15 Mar 2024 | Human Drugs | WL | View 483 → |
| 16 Aug 2021 – 20 Aug 2021 | Human Drugs | 483 | View 483 → |
| 17 Dec 2018 – 15 Feb 2019 | Human Drugs | WL | View 483 → |
| 3 Jan 2017 – 25 Jan 2017 | Human Drugs | 483 | View 483 → |
| 20 Feb 2014 – 1 Apr 2014 | Human Drugs | 483 | View 483 → |
| 30 Mar 2012 | Not recorded | 483 | View 483 → |
| 24 Nov 2010 | Not recorded | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
15 Mar 2024
21 CFR 211.113(a)
Procedures for non-sterile drug products
Cited by Saundrea A Munroe, Michael H Tollon, Kayla V Sprague
15 Mar 2024
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Saundrea A Munroe, Michael H Tollon, Kayla V Sprague
15 Mar 2024
21 CFR 211.165(a)
Testing and release for distribution
Cited by Saundrea A Munroe, Michael H Tollon, Kayla V Sprague
15 Mar 2024
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Saundrea A Munroe, Michael H Tollon, Kayla V Sprague
15 Mar 2024
21 CFR 211.63
Equipment Design, Size and Location
Cited by Saundrea A Munroe, Michael H Tollon, Kayla V Sprague
Investigators
FDA investigators tied to this site in the record.
Michael H Tollon4 insp.
Saundrea A Munroe3 insp.
Kayla V Sprague1 insp.
Nakesha J Jackson1 insp.
Nicole E Knowlton1 insp.
Jennifer A Robinson1 insp.
Mizanne E Lewis1 insp.
Daryl A Dewoskin1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.166(b) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.165(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.180(e)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.182 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.204 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Belleview Biosciences LLC's 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat